Amprya is an oral medication prescribed for patients withMultiple Sclerosis (MS). MS is a disease that affects several different systems in the body. MS is anautoimmune diseasewhere the immune system incorrectly attacks parts of the body. In MS, the immune system attacks the myelin sheaths that protect nerve cells. The breakdown ofmyelin sheathsaffects the connections between the brain and several parts of the body, including the eyes, the limbs, and sexual organs. It can cause fatigue, cognitive problems, pain, and other symptoms. Amprya is indicated to improve walking in adults with MD. Fact Table Formula C5H6N2 License US FDA, EU EMA Bioavailability 96% Legal status Rx-Only Chemical Name Dalfampridine Elimination half-life 125 +/- 23 min Dosage (Strength) 10mg Pregnancy Consult Doctor Brands Ampyra Protein binding 3–7% PubChem CID 1727 MedlinePlus a611005 ChEBI 34345 ATC code N07XX07 DrugBank DB06637 KEGG D04127 Routes of administration Oral
Ampyra (dalfampridine er)
- The standard and maximum doses are 10 mg by mouth every 12 hours. Amprya may be taken with or without food. The capsules should not be crushed, chewed, and opened. If you miss a dose, do not take double the amount. Call your pharmacist for directions on what to do.
